Signaturefd LLC Grows Stock Holdings in The Clorox Company (NYSE:CLX)

Signaturefd LLC raised its stake in The Clorox Company (NYSE:CLX) by 7.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,840 shares of the company’s stock after buying an additional 404 shares during the period. Signaturefd LLC’s holdings in Clorox were worth $833,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Qube Research & Technologies Ltd grew its holdings in Clorox by 75.9% in the third quarter. Qube Research & Technologies Ltd now owns 1,130,481 shares of the company’s stock valued at $148,161,000 after purchasing an additional 487,974 shares during the last quarter. International Assets Investment Management LLC increased its holdings in Clorox by 17,658.5% during the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after acquiring an additional 481,725 shares in the last quarter. Acadian Asset Management LLC lifted its holdings in shares of Clorox by 39.6% in the third quarter. Acadian Asset Management LLC now owns 1,467,713 shares of the company’s stock valued at $192,319,000 after purchasing an additional 415,999 shares in the last quarter. FMR LLC grew its position in shares of Clorox by 17.4% in the third quarter. FMR LLC now owns 2,415,054 shares of the company’s stock valued at $316,517,000 after purchasing an additional 357,964 shares during the last quarter. Finally, Nuance Investments LLC increased its stake in shares of Clorox by 25.7% during the 3rd quarter. Nuance Investments LLC now owns 1,325,789 shares of the company’s stock worth $173,758,000 after purchasing an additional 271,133 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 1.1 %

Shares of Clorox stock opened at $145.19 on Tuesday. The business has a 50-day moving average price of $149.82 and a 200 day moving average price of $142.09. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $178.21. The firm has a market cap of $18.02 billion, a P/E ratio of 230.46, a P/E/G ratio of 2.27 and a beta of 0.43. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The business had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the previous year, the business earned $0.98 EPS. The business’s quarterly revenue was up 16.0% on a year-over-year basis. On average, sell-side analysts forecast that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be issued a $1.20 dividend. This represents a $4.80 annualized dividend and a dividend yield of 3.31%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is presently 761.92%.

Analysts Set New Price Targets

A number of brokerages have commented on CLX. UBS Group increased their target price on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, February 2nd. DA Davidson reissued a “neutral” rating and issued a $162.00 price objective on shares of Clorox in a research report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research report on Wednesday, April 17th. Citigroup cut their price target on Clorox from $165.00 to $155.00 and set a “neutral” rating for the company in a report on Tuesday, April 16th. Finally, Morgan Stanley restated an “equal weight” rating and set a $160.00 price objective on shares of Clorox in a report on Tuesday, March 26th. Four investment analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $148.63.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.